New infant-friendly formulation closes a critical treatment gap for the youngest children, with support from African-led trials and global partners.Addis Ababa, 16 August 2025 - The Africa Centres for ...

A health worker administers the malaria vaccine Oxford-Serum R21 to a child in Abidjan, Ivory Coast, 15 July 2024 ...

First Malaria Drug for InfantsThe Africa Centres for Disease Control and Prevention (Africa CDC) welcomed the approval of the first malaria treatment designed for newborns and infants under five ...

The Africa Centres for Disease Control and Prevention (Africa CDC) has reported a significant drop in mpox cases across the ...

Nigeria has joined seven other African nations in pioneering a clinical trial that has resulted in the approval of the first ...

Nigeria has been named among eight African countries that contributed to a clinical trial leading to the approval of the ...

As international funding rapidly recedes, African countries — among those with the highest new HIV infection rates are ...

Nigeria has been named among eight African countries involved in the clinical trial of the world’s first malaria treatment ...

Mpox remains a serious public health challenge in Africa. In the past year, 28 African countries have been affected, with ...

For the first time, newborns and infants weighing less than five kilogrammes will have access to a newly approved malaria treatment, whose clinical trials were conducted in eight African countries.